Document is current
Any future updates will be listed below
-
Authors
Greaney, Allison J. https://orcid.org/0000-0001-7202-3349
Starr, Tyler N. https://orcid.org/0000-0001-6713-6904
Barnes, Christopher O.
Weisblum, Yiska
Schmidt, Fabian
Caskey, Marina
Gaebler, Christian
Cho, Alice
Agudelo, Marianna
Finkin, Shlomo
Wang, Zijun
Poston, Daniel
Muecksch, Frauke
Hatziioannou, Theodora https://orcid.org/0000-0002-7889-0766
Bieniasz, Paul D. https://orcid.org/0000-0002-2368-3719
Robbiani, Davide F.
Nussenzweig, Michel C.
Bjorkman, Pamela J. https://orcid.org/0000-0002-2277-3990
Bloom, Jesse D. https://orcid.org/0000-0003-1267-3408
- License Information
-
More Information
Article History
Received: 18 May 2021
Accepted: 11 June 2021
First Online: 7 July 2021
Competing interests
: Subsequent to completion and submission of the initial version of this study, J.D.B. began consulting for Moderna on viral evolution and epidemiology. J.D.B. has the potential to receive a share of IP revenue as an inventor on a Fred Hutch optioned technology/patent (application WO2020006494) related to deep mutational scanning of viral proteins. The Rockefeller University has filed a provisional patent application related to SARS-CoV-2 monoclonal antibodies on which D.F.R. and M.C.N. are inventors. The Rockefeller University has applied for a patent relating to the replication-competent VSV/SARS-CoV-2 chimeric virus on which Y.W, F.S., T.H. and P.B. are inventors (US patent 63/036,124). The remaining authors declare no competing interests.
